# RUXOLITINIB
> **ANDA220375** · Abbreviated New Drug Application (Generic) · Sponsor: TORRENT PHARMACEUTICALS LTD · Approved 2026-03-23
## Drug
- **FDA Application Number:** ANDA220375
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RUXOLITINIB
- **Generic name:** Ruxolitinib
- **Active ingredients:** RUXOLITINIB
- **Dosage form:** TABLET
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** TORRENT PHARMACEUTICALS LTD
- **First approval:** 2026-03-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220375)
---
*MORVS · CC0 1.0*